In May possibly 2019, a demo at Nanjing College Medical center commenced comparing dapagliflozin to liraglutide, and to the anti-diabetic medication acarbose, for his or her respective results on cognitive and olfactory function in 87 overweight men and women whose Kind 2 diabetic issues is poorly controlled with metformin by https://adama222oal6.bcbloggers.com/profile